Chronic Total Occlusion (CTO)
14
5
7
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Contemporary Practice
Predictors and Long-term Incidence of In-stent Restenosis After Chronic Total Occlusion Percutaneous Coronary Intervention
Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions
Chronic Total Occlusion and Triglyceride-Glucose Index
AGECTO Study: PCI vs. Optimal Medical Therapy for CTO in the Octogenarian Patients
TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)
Coronary Laser in Undilatable or Uncrossable Lesions
FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion
Remodeling of Distal Coronary Vessel in Chronic Total Occlusions: Prediction Based on Hemodynamic Coronary Parameters
FAPI Imaging Assessment of Chronic Total Occlusion
Feasibility of a Cardiac Rehabilitation Program for CTO Patients Before PCI Treatment
A Novel Scoring System for Predicting the Success of PCI in Patients With CTO
A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross Single-Use Microcatheter
EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions